Of note, an abnormal CD19+ IgM- IgD- CD21lo subset has been identified in systemic sclerosis and anti-histidyl tRNA synthetase syndrome, which expresses many innate immune cell markers (unpublished observations). This evidence concerns the gene CD19 and systemic sclerosis.